Australian consumers want more access to affordable medicines, new GMiA research shows

17 September 2012

A new survey shows 75% of Australians believe that the government should offer a price discount to consumers who choose generic medicines, which drive significant savings to the economy, over branded medicines.

The national survey of more than 1,000 respondents reveals that Australians are very positive about generic medicines, with 89% of Australians rating generic prescription medicines as “a product I know and trust.” Most people will trust their doctor (84%) and their pharmacist (86%) to help direct them regarding which medicine to purchase.

The Australian Generic Medicines Industry Association (GMiA) commissioned the research to assess the public’s appetite to introduce policy that supports increased use of generic prescription medicines in the community. Using generic medicines saves the economy millions of dollars. In fact, every time a generic is dispensed there are savings, yet there is often no direct financial benefit to those who need it most – concession cardholders and consumers who purchase prescription medicines frequently.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics